According to a new study, there is no increased risk of infections in pediatric psoriasis (PsO) patients treated with ustekinumab compared to etanercept or methotrexate.
top of page
bottom of page
According to a new study, there is no increased risk of infections in pediatric psoriasis (PsO) patients treated with ustekinumab compared to etanercept or methotrexate.
Kommentare